GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (LSE:POLB) » Definitions » ROE % Adjusted to Book Value

Poolbeg Pharma (LSE:POLB) ROE % Adjusted to Book Value : -6.46% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Poolbeg Pharma ROE % Adjusted to Book Value?

Poolbeg Pharma's ROE % for the quarter that ended in Jun. 2024 was -33.59%. Poolbeg Pharma's PB Ratio for the quarter that ended in Jun. 2024 was 5.20. Poolbeg Pharma's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -6.46%.


Poolbeg Pharma ROE % Adjusted to Book Value Historical Data

The historical data trend for Poolbeg Pharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poolbeg Pharma ROE % Adjusted to Book Value Chart

Poolbeg Pharma Annual Data
Trend Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
-4.91 -13.97 -7.69

Poolbeg Pharma Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROE % Adjusted to Book Value Get a 7-Day Free Trial -11.66 -19.01 -8.24 -8.77 -6.46

Competitive Comparison of Poolbeg Pharma's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Poolbeg Pharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Poolbeg Pharma's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poolbeg Pharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Poolbeg Pharma's ROE % Adjusted to Book Value falls into.



Poolbeg Pharma ROE % Adjusted to Book Value Calculation

Poolbeg Pharma's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-24.00% / 3.12
=-7.69%

Poolbeg Pharma's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-33.59% / 5.20
=-6.46%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Poolbeg Pharma ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Poolbeg Pharma's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Poolbeg Pharma Business Description

Traded in Other Exchanges
Address
42 New Road, Queen Mary BioEnterprises Innovation Centre, London, GBR, E1 2AX
Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.

Poolbeg Pharma Headlines

No Headlines